KALA BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.512 USD | +0.18% |
|
-0.59% | -6.98% |
| 17/05 | HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating | MT |
| 02/04 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA BIO, INC. | Other Pharmaceuticals | +0.18% | -0.59% | -6.98% | -56.73% | -97.81% | 18.34M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- KALA Stock
- Charts KALA BIO, Inc.
- Comparison Chart
